Logo

Perlegen's California Lab Gains CLIA Certification

Jun 05, 2009

NEW YORK (GenomeWeb News) – Genetic testing company Perlegen Sciences has received certification for a new clinical lab in Mountain View, Calif., the company said today.

The company said it received Clinical Laboratory Improvement Amendments certification from the California Department of Public Health's Laboratory Field Services and has opened the facility.

Perlegen CEO Bryan Walser said in a statement that the opening of the lab is "a significant advance in our efforts to commercialize Perlegen's key genetic tests," which the company will begin with the launch this fall of the MammaPlus genetic test for breast cancer risk.

Filed under

Diagnostics
Perlegen
Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.